Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver

Authors

  • Claudia Zwingmann,

    Corresponding author
    1. From the Centre de recherche, Centre hospitalier de l'Université de Montréal (CHUM), Hôpital Saint-Luc, Montreal, Quebec, Canada
    • Centre de recherche, CHUM, Hôpital Saint-Luc, 264 Boul. René-Lévesque Est., Montréal, Québec H2X 1P1, Canada
    Search for more papers by this author
    • fax: 514-412-7314

  • Marc Bilodeau

    1. From the Centre de recherche, Centre hospitalier de l'Université de Montréal (CHUM), Hôpital Saint-Luc, Montreal, Quebec, Canada
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Abstract

The hepatoprotective mechanisms of N-acetylcysteine (NAC) in non–acetaminophen-induced liver injury have not been studied in detail. We investigated the possibility that NAC could affect key pathways of hepatocellular metabolism with or without changes in glutathione (GSH) synthesis. Hepatocellular metabolites and high-energy phosphates were quantified from mouse liver extracts by 1H- and 31P-NMR (nuclear magnetic resonance) spectroscopy. 13C-NMR-isotopomer analysis was used to measure [U-13C]glucose metabolism through pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC). NAC (150-1,200 mg/kg) increased liver concentrations of GSH from 8.60 ± 0.48 to a maximum of 12.95 ± 1.03 μmol/g ww, whereas hypotaurine (HTau) concentrations increased from 0.05 ± 0.02 to 9.95 ± 1.12 μmol/g ww. The limited capacity of NAC to increase GSH synthesis was attributed to impaired glucose metabolism through PC. However, 300 mg/kg NAC significantly increased the fractional 13C-enrichment in Glu (from 2.08% ± 0.26% to 4.00% ± 0.44%) synthesized through PDH, a key enzyme for mitochondrial energy metabolism. This effect could be uncoupled from GSH synthesis and was associated with the prevention of liver injury induced by tert-butylhydroperoxide and 3-nitropropionic acid. In conclusion, NAC (1) has a limited capacity to elevate GSH synthesis; (2) increases HTau formation linearly; and (3) improves mitochondrial tricarboxylic acid (TCA) cycle metabolism by stimulation of carbon flux through PDH. This latter effect is independent of the capacity of NAC to replete GSH stores. These metabolic actions, among other yet unknown effects, are critical for NAC's therapeutic value and should be taken into account when deciding on a wider use of NAC. (HEPATOLOGY 2006;43:454–463.)

Ancillary